The role of novel oncogenes squamous cell carcinoma-related oncogene and Phosphatidylinositol 3-kinase p110α in squamous cell carcinoma of the oral tongue
Ashok R. Shaha , Pornchai O-charoenrat , Cherry L. Estilo , Joseph M. Huryn
Clinical Cancer Research 9 ( 6) 2300 -2306
68
2003
Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).
Hilda Stambuk , Katherine W. Kelly , Matthew G. Fury , Sofia Haque
Anticancer Research 31 ( 1) 249 -253
63
2011
Initial clinical trial of a high-affinity retinoic acid receptor ligand (LGD1550).
David G. Pfister , Barbara A. Parker , Raymond P. Warrell , Vincent A. Miller
Clinical Cancer Research 6 ( 5) 1731 -1735
12
2000
Classifying Clinical Severity to Help Solve Problems of Stage Migration in Nonconcurrent Comparisons of Lung Cancer Therapy
Alvan R. Feinstein , Carolyn K. Wells , Charles K. Chan , David G. Pfister
Cancer Research 50 ( 15) 4664 -4669
12
1990
Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.
Mark G. Kris , Robert T. Heelan , Katherine M. W. Pisters , Greg Chronowski
Clinical Cancer Research 7 ( 3) 501 -509
2
2001
High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancer.
Mark G. Kris , George Krol , Leslie B. Tyson , Vincent A. Miller
Clinical Cancer Research 2 ( 11) 1819 -1824
1
1996
Revisiting induction chemotherapy for head and neck cancer - References and reviews: Commentary
Bruce Brockstein , Everett E. Vokes , David G. Pfister , Yungpo Bernard Su
Oncology 19 ( 7) 939 -945
2005
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Arlene A. Forastiere , Nofisat Ismaila , Jan S. Lewin , Cherie Ann Nathan
Journal of Clinical Oncology 36 ( 11) 1143 -1169
236
2017
Preliminary results from KEYNOTE-055: Pembrolizumab after platinum and cetuximab failure in head and neck squamous cell carcinoma (HNSCC).
Joshua Bauml , Tanguy Y. Seiwert , David G. Pfister , Francis P. Worden
Journal of Clinical Oncology 34 6011 -6011
15
2016
Changes in body composition and prognostic importance of sarcopenia in patients receiving CTRT for oropharyngeal cancer.
Shrujal S. Baxi , Lee Jones , Anne Eaton , Stephanie Gandelman
Journal of Clinical Oncology 34 6077 -6077
3
2016
Enhancing radioiodine (RAI) incorporation into BRAFV600E-mutant, RAI-refractory thyroid cancers with the BRAF inhibitor vemurafenib: A pilot study.
Lara Dunn , Eric Jeffrey Sherman , Shrujal S. Baxi , Ravinder K. Grewal
Journal of Clinical Oncology 34 6099 -6099
3
2016
Phase II study of regorafenib in progressive, recurrent/metastatic adenoid cystic carcinoma.
Alan Loh Ho , Eric Jeffrey Sherman , Shrujal S. Baxi , Sofia Haque
Journal of Clinical Oncology 34 6096 -6096
8
2016
Radiation therapy and low dose doxorubicin in thyroid cancer: A phase II study.
Eric Jeffrey Sherman , Paul Bernard Romesser , Alan Loh Ho , Shrujal S. Baxi
Journal of Clinical Oncology 34 6100 -6100
2
2016
A patient safety approach to assessing adverse events in oncology: Results from CHARM (Cancer Harm) study.
Allison Nicole Lipitz Snyderman , David Classen , David G. Pfister , Aileen Killen
Journal of Clinical Oncology 34 6601 -6601
2016
Feasibility of incorporating patient reported outcomes (PROs) into routine care for oropharyngeal carcinoma (OPC).
Shrujal S. Baxi , Jennifer R Cracchiolo , Snehal G. Patel , Sean Matthew McBride
Journal of Clinical Oncology 35
2017
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer
Eric J. Sherman , Lara A. Dunn , Alan L. Ho , Shrujal S. Baxi
Cancer 123 ( 21) 4114 -4121
31
2017
Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer.
Eric J. Sherman , Lara A. Dunn , Heiko Schöder , Alan L. Ho
Cancer 125 ( 17) 2984 -2990
3
2019
The 3 Bs of cancer care amid the COVID-19 pandemic crisis: “Be safe, be smart, be kind”—A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer
Jung Julie Kang , Richard J. Wong , Eric J. Sherman , Alisa Rybkin
Cancer 126 ( 18) 4092 -4104
6
2020
Case study of the integration of electronic patient-reported outcomes as standard of care in a head and neck oncology practice: Obstacles and opportunities
Olga Strachna , Marc A. Cohen , Monica M. Allison , David G. Pfister
Cancer 127 ( 3) 359 -371
2021